Richard Rodgers
Director/Board Member bij ARDELYX, INC.
Vermogen: 2 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
David Mott | M | 58 | 15 jaar | |
Elizabeth Grammer | F | 60 | 12 jaar | |
James Young | M | 71 | 14 jaar | |
George Kemble | M | 63 | 13 jaar | |
John Trizzino | M | 64 | 10 jaar | |
Justin Renz | M | 52 | 4 jaar | |
Merdad Parsey | M | 61 | 14 jaar | |
Beth Seidenberg | M | 67 | 17 jaar | |
Robert Felsch | M | - | 4 jaar | |
Bernhard Hoffmann | M | 68 | 6 jaar | |
John Jacobs | M | 57 | 1 jaar | |
Amy Rabourn | F | 44 | 5 jaar | |
Cam Gallagher | M | 54 | 5 jaar | |
David Happel | M | 62 | 2 jaar | |
Mike Raab Raab | M | 59 | 15 jaar | |
Joseph Oriti | M | 44 | - | |
Onaiza Cadoret-Manier | F | 60 | 4 jaar | |
William Bertrand | M | 59 | 9 jaar | |
Gregg Alton | M | 58 | 4 jaar | |
Caitlin Lowie | F | - | 2 jaar | |
Jay Pepose | M | 69 | 3 jaar | |
Erik Sims | M | - | 3 jaar | |
Muna Bhanji | F | 61 | 3 jaar | |
James Armitage | M | 77 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 14 jaar |
Mark Joseph Casey | M | 60 | 1 jaar | |
Laura Williams | M | 61 | 4 jaar | |
Rachel King | F | 64 | 6 jaar | |
George Magrath | M | 40 | 1 jaar | |
Brian Rosen | M | - | 9 jaar | |
Sean Ainsworth | M | 56 | 6 jaar | |
Robert B. Bazemore | M | 56 | 8 jaar | |
Elizabeth Rozek | F | 53 | 1 jaar | |
Silvia Taylor | F | - | 4 jaar | |
Margaret McGlynn | F | 64 | 4 jaar | |
James Kelly | M | 58 | 3 jaar | |
Richard Douglas | M | 71 | 14 jaar | |
Gale Smith | M | - | 20 jaar | |
Susan Benton | F | 59 | 4 jaar | |
James Manuso | M | 75 | 5 jaar | |
Jan Lundberg | M | 70 | 6 jaar | |
Seth Toback | M | - | 4 jaar | |
Barbara Withers | F | - | - | |
Johann Bono | M | - | - | |
Ursula Matulonis | F | - | - | |
Raburn Mallory | M | - | 4 jaar | |
Denny Kim | M | - | 3 jaar | |
Susan Rodriguez | F | 60 | 4 jaar | |
Charon Spencer | F | - | 1 jaar | |
Erika Schultz | F | - | - | |
Alison Chartan | F | - | 3 jaar | |
Duncan Jodrell | M | - | - | |
Henrietta Ukwu | M | 64 | 3 jaar | |
Troy Morgan | M | - | 3 jaar | |
Drey Coleman | F | - | - | |
Iksung Cho | M | - | 9 jaar | |
Filip Dubovsky | M | 59 | 4 jaar | |
Biegie Lee | M | - | 7 jaar | |
Chris Dunne | M | - | 14 jaar | |
Timothy Jon Hahn | M | 60 | 4 jaar | |
Eduardo Bruno Martins | M | 61 | 3 jaar | |
Frank D. Czworka | M | 55 | 4 jaar | |
Gaeton Biscardi | M | - | - | |
Robert Blanks | M | 64 | 11 jaar | |
Anne-Marie O'Farrell | M | - | 11 jaar | |
Mitchell Brigell | M | - | - | |
Arnold Lewis Oronsky | M | 83 | 13 jaar | |
David Rosenbaum | M | 63 | 14 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Mary Lynne Hedley | M | 61 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 16 jaar |
Douglas Swirsky | M | 54 | 2 jaar | |
Lonnie Moulder | M | 66 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 10 jaar |
Mina Sooch | F | 56 | 5 jaar | |
Chang Ho Ahn | M | 72 | 16 jaar | |
Stanley Erck | M | 76 | 14 jaar | |
Mark E. Kaufmann | M | 56 | 9 jaar | |
Gordon Ringold | M | 73 | 14 jaar | |
Dominique Charmot | M | 69 | 7 jaar | |
John Herrmann | M | 58 | 13 jaar | |
Patrick Soon-Shiong | M | 71 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 3 jaar |
Richard R. Roscitt | M | 72 | 2 jaar | |
Tae Heum Jeong | M | 53 | 15 jaar | |
Peter G. Schultz | M | 67 | 8 jaar | |
Edward C. English | M | 57 | 5 jaar | |
Anthony Rimac | M | 60 | 1 jaar | |
Joseph Stich | M | 59 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 5 jaar |
Jennifer Davis Ruff | F | - | 5 jaar | |
Jeffrey W. Jacobs | M | 61 | 13 jaar | |
Annalisa Jenkins | M | 58 | 5 jaar | |
Jill Hoyt | F | - | 15 jaar | |
Paul Walker | M | 49 | 4 jaar | |
David F. Fisher | M | 75 | 5 jaar | |
Jean M. Fréchet | M | - | 7 jaar | |
David Collier | M | 61 | - | |
Russell Wilson | M | 64 | 12 jaar | |
Mark P. Carthy | M | 63 | 4 jaar | |
Chris Rasmussen | M | - |
The Curtis L. Carlson School of Management
| 7 jaar |
Alan R. Meyer | M | - | 3 jaar | |
William Cadogan | M | 75 | 14 jaar | |
David Martin McIntosh | M | 65 | 11 jaar | |
Jared Oasheim | M | 41 |
The Curtis L. Carlson School of Management
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Richard Rodgers
- Persoonlijk netwerk